Asia Pacific Cancer Photodynamic Therapy Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
USD
738.34 Million
USD
1,383.02 Million
2024
2032
 예측 기간 |
2025 –2032 |
 시장 규모(기준 연도) |
USD 738.34 Million |
 시장 규모(예측 연도) |
USD 1,383.02 Million |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
|
아시아 태평양 암 광역학 치료 시장, 제품 유형별(광감각제 약물, 광역학 치료 장치, 액세서리 및 소모품), 암 적응증별(피부 및 피부 종양학, 두경부, 식도, 폐, 방광, 자궁경부, 전립선), 치료 방식별(단독 치료, 보조 치료, 완화 치료, 병용 치료, 기타), 시술 기술별(외부 빔, 간질 전달, 체강 내 전달, 수술 중 전달, 기타), 질병 단계별(초기 암, 후기 암), 환자 인구 통계별(소아, 성인, 노인), 최종 사용자별(병원, 피부과 및 피부암 클리닉, 외래 수술 센터, 학술 및 연구 기관, 기타), 유통 채널별(직접 입찰, 제3자 유통업체, 온라인, 기타) - 산업 동향 및 예측 2032년.
아시아 태평양 암 광역학 치료 시장 규모
- 아시아 태평양 암 광역학 치료 시장은 2024년에 7억 3,834만 달러 규모로 평가되었으며, 예측 기간 동안 8.3%의 CAGR 로 2032년까지 1,383.02만 달러 에 도달할 것으로 예상됩니다 .
- 이 시장은 주로 암 유병률 증가, 의료비 지출 증가, 그리고 첨단 치료 옵션에 대한 인식 제고에 의해 주도되고 있습니다. 의료 인프라의 급속한 개선, 전문 암 치료 센터의 확장 등이 이러한 추세를 뒷받침합니다.
- 이러한 성장은 조기 진단 및 혁신적 치료법을 장려하는 정부 이니셔티브, 대규모 환자 풀, 광역학 치료 기술에 대한 국제 및 국내 기업의 투자 증가와 같은 요인에 의해 촉진됩니다.
아시아 태평양 암 광역학 치료 시장 분석
- 암 광역학 치료(PDT) 시장은 암 유병률 증가, 비침습적 치료에 대한 인식 증가, 광감각제 약물 및 레이저 기술의 발전에 힘입어 꾸준한 성장을 경험하고 있습니다.
- 신흥 시장에서는 정부 정책, 의료비 지출 증가, 그리고 노령 인구 증가에 힘입어 광역학 치료(PDT) 도입이 빠르게 증가하고 있습니다. 그러나 높은 치료비와 제한된 보험 급여는 여전히 주요 제약으로 남아 있는 반면, 병용 요법과 표적 광감작제 분야의 지속적인 혁신은 상당한 성장 기회를 제공합니다.
- 중국은 2025년 아시아 태평양 암 광역학 치료 시장에서 43.73%의 최대 매출 점유율을 기록하며 시장을 장악할 것으로 예상됩니다. 이는 풍부한 환자층, 증가하는 암 유병률, 그리고 증가하는 의료비 지출에 힘입은 것입니다. 첨단 암 치료에 대한 강력한 정부 지원, 혁신적 치료법 도입 확대, 그리고 주요 국내 PDT 기기 제조업체들의 존재감 등이 그 배경이 될 것입니다.
- 일본은 예측 기간 동안 아시아 태평양 암 광역학 치료 시장에서 연평균 성장률 8.9%로 가장 빠르게 성장할 것으로 예상됩니다. 이는 암 유병률 증가, 고도로 발달된 의료 인프라, 그리고 혁신적인 치료법에 대한 정부의 강력한 지원에 힘입은 것입니다. 환자와 의사의 인식 제고와 최소 침습 치료법 도입이 맞물려 수요가 급증하고 있습니다.
- 광감각제 약물 부문은 다양한 암에 대한 광역학 치료의 채택 증가, 새로운 광감각제 승인 증가, 지역 전체에서 최소 침습 치료 옵션에 대한 선호도 증가에 힘입어 2025년에 76.15%의 시장 점유율로 아시아 태평양 암 광역학 치료 시장을 지배할 것으로 예상됩니다.
보고서 범위 및 아시아 태평양 암 광역학 치료 시장 세분화
|
속성 |
아시아 태평양 실크 주요 시장 통찰력 |
|
다루는 세그먼트 |
|
|
포함 국가 |
아시아 태평양
|
|
주요 시장 참여자 |
|
|
시장 기회 |
|
|
부가가치 데이터 정보 세트 |
Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체 등 시장 시나리오에 대한 통찰력 외에도 수입 수출 분석, 생산 능력 개요, 생산 소비 분석, 가격 추세 분석, 기후 변화 시나리오, 공급망 분석, 가치 사슬 분석, 원자재/소모품 개요, 공급업체 선택 기준, PESTLE 분석, Porter 분석 및 규제 프레임워크가 포함됩니다. |
아시아 태평양 암 광역학 치료 시장 동향
“다른 암 치료법과의 통합”
- 광역학 치료(PDT)는 면역 반응을 자극하는 동시에 국소적인 종양 세포 사멸을 일으킬 수 있는 능력으로 인해 다중 모드 암 치료에 매력적인 파트너로 자리매김하고 있습니다.
- 증가하는 증거에 따르면 PDT는 종양 항원 방출을 증가시키고, 종양 미세환경을 조절하며, 면역 세포의 침투나 활성화를 향상시킬 수 있습니다. 이러한 메커니즘은 면역 체크포인트 억제제, 치료용 암 백신, 화학 요법 또는 방사선 요법과 함께 사용하면 상승 효과를 얻을 수 있습니다.
- PDT를 전신 치료법과 결합하면 국소적 조절을 지속 가능한 전신적 반응으로 전환하고, 독성 물질의 복용량을 줄이고, 적응증(예: 절제 불가능하거나 전이성 질환)을 확대할 수 있습니다.
- 임상 및 전환 연구가 증가함에 따라 다른 방식과의 통합은 PDT의 임상적 관련성과 상업적 활용을 확대하는 고가치 경로를 나타냅니다.
아시아 태평양 암 광역학 치료 시장 동향
운전사
“암 유병률 증가”
- 전 세계적으로 암 유병률이 증가하는 것은 광역학 치료(PDT)와 같은 치료법에 대한 수요를 촉진하는 가장 큰 요인 중 하나입니다.
- 인구가 증가하고 고령화되고 진단 도구가 발전함에 따라 매년 더 많은 암 사례가 발견되고 있습니다.
- 저소득 및 중소득 국가에서는 흡연, 비만, 앉아서 보내는 생활 방식, 대기 오염, 감염 등의 위험 요소가 높아지는 것도 발병률이 증가하는 데 영향을 미칩니다.
- 점점 더 많은 환자가 효과적이고, 침습성이 적으며, 비용 효율적인 국소 치료 방식을 필요로 함에 따라 PDT가 더욱 매력적으로 다가오고 있습니다.
- 이러한 암 부담의 증가는 건강 시스템에 스트레스를 주어 결과를 개선하고 부작용을 줄이며 보다 광범위하게 배포할 수 있는 치료법에 대한 긴급한 압력을 발생시킵니다.
제지/도전
"제한된 빛 투과 깊이"
- 광역학 치료의 폭넓은 채택과 효과를 방해하는 주요 한계는 활성화된 빛이 인체 조직으로 침투하는 데 제한이 있다는 것입니다.
- 광감각제는 특정 파장의 빛에 의해 활성화되어야 하므로 조직에 의한 빛의 흡수와 산란으로 인해 조명이 도달할 수 있는 깊이가 줄어듭니다.
- 가시광선 PS는 종종 표면적이거나 쉽게 접근 가능한 종양에만 효과가 있으며, 더 깊거나 더 큰 종양은 여전히 어렵습니다.
- 이러한 제한으로 인해 종양이 완전히 파괴되지 않고, 침습적 빛 조사(예: 광섬유 프로브, 내시경)가 필요해지고, 시술이 복잡해지고, 좋지 않은 결과나 재발로 이어질 수 있습니다.
- 획기적인 발전이 이를 극복할 때까지 PDT는 비침습적이고 효과적으로 치료할 수 있는 암의 범위가 제한됩니다.
아시아 태평양 암 광역학 치료 시장 범위
시장은 제품 유형, 암 적응증, 치료 방식, 시술 기술, 질병 단계, 환자 인구 통계, 최종 사용자 및 유통 채널을 기준으로 세분화됩니다.
- 제품 유형별
아시아 태평양 암 광역학 치료 시장은 제품 유형을 기준으로 광감작제와 광역학 치료 기기로 구분됩니다. 2025년에는 광감작제 부문이 치료 효능에 중요한 역할을 하고, 다양한 암 유형에 광범위하게 적용 가능하며, 다양한 제형(정맥, 국소, 경구, 방광, 복강 내)을 갖추고 있어 75.38%의 시장 점유율을 기록하며 시장을 장악할 것으로 예상됩니다. 이러한 시장 지배력을 뒷받침하는 주요 요인으로는 암 유병률 증가, 최소 침습 치료법 도입 증가, 지속적인 약물 혁신, 그리고 규제 기관의 승인 등이 있으며, 이러한 요소들이 합쳐져 광감작제가 PDT 기기보다 주요 매출원으로서의 위치를 차지하고 있습니다.
광감작제 약물은 표적 및 최소 침습 암 치료법의 도입 증가로 인해 아시아 태평양 암 광역학 치료 시장에서 가장 빠르게 성장하는 부문으로, 연평균 성장률 6.8%를 기록하고 있습니다. PDT의 효과에 대한 인지도 향상, 기존 치료법 대비 부작용 감소, 그리고 종양 선택성이 향상되고 조직 침투력이 더 깊은 차세대 광감작제 개발이 수요를 견인하고 있습니다. 또한, 새로운 광감작제에 대한 임상 연구 및 승인 확대는 시장 확대를 촉진하고 있습니다.
- 암 징후에 따라
아시아 태평양 암 광역학 치료 시장은 암 적응증을 기준으로 피부 및 피부 종양학, 두경부, 식도, 폐, 방광, 자궁경부, 전립선으로 세분화됩니다. 2025년에는 피부 및 피부 종양학 분야가 피부암의 높은 유병률, 조기 발견에 대한 광범위한 인식, 그리고 탁월한 미용적 결과를 달성하는 PDT의 효과로 인해 52.59%의 시장 점유율을 차지하며 시장을 장악할 것으로 예상됩니다. 이 분야는 광감각제 약물과 PDT 기기의 광범위한 도입, 특히 환자 수가 가장 많은 노인 및 성인 환자를 위한 혜택을 누리고 있습니다. 또한, 광선각화증, 기저세포암, 편평세포암에 대한 최소 침습 표적 치료법에 대한 수요 증가와 주요 지역의 유리한 보험급여 정책은 다른 암 적응증에 대한 시장 선도력을 더욱 강화하고 있습니다.
피부 및 피부 종양학 분야는 피부암 유병률 증가, 조기 진단에 대한 인식 제고, 그리고 부작용이 적은 최소 침습적 치료법에 대한 선호로 인해 아시아 태평양 암 광역학 치료 시장에서 연평균 성장률 7.3%로 가장 빠르게 성장하고 있습니다. 광역학 치료는 표적 치료 효과, 빠른 회복, 그리고 향상된 미용적 효과를 제공하여 피부 종양학 분야에 매우 유리한 위치를 차지하고 있습니다. 또한, 광감작제와 광 전달 시스템의 기술 발전이 이 분야의 도입을 촉진하고 있습니다.
- 치료 방식에 따라
아시아 태평양 암 광역학 치료 시장은 치료 방식에 따라 단독 치료, 보조 치료, 완화 치료, 기타로 구분됩니다. 2025년에는 단독 치료 부문이 피부암, 식도암, 폐암을 포함한 국소 암의 1차 치료법으로서의 효과로 시장 점유율 41.67%를 차지하며 시장을 장악할 것으로 예상됩니다. 이러한 우위를 점하는 주요 요인으로는 높은 효능, 최소 침습성, 우수한 미용적 효과, 그리고 표적 치료에 대한 임상적 선호도 증가가 있습니다. 지역적으로는 아시아 태평양 지역이 선진 의료 인프라, 확립된 보험급여 체계, 그리고 높은 환자 인지도로 단독 광역학 치료(PDT) 도입을 주도하고 있으며, 아시아 태평양 신흥 시장에서는 암 유병률 증가, 병원 네트워크 확장, 그리고 현대 종양학 치료법 접근성 향상에 힘입어 도입률이 증가하고 있습니다. 이러한 지역적 역동성과 광역학 치료(PDT)의 이점에 대한 교육 및 인지도 향상은 전 세계적으로 단독 치료의 우위를 더욱 강화하고 있습니다.
단독 치료는 아시아 태평양 암 광역학 치료 시장에서 연평균 성장률 7.2%로 가장 빠르게 성장하는 분야입니다. 이는 단순성, 비용 효율성, 그리고 병용 요법 대비 부작용 감소 덕분입니다. 단독 치료는 추가 약물이나 중재 없이 표적 종양 치료를 가능하게 하여 환자의 순응도를 향상시킵니다. 외래 환자 진료에서의 도입률 증가, 최소 침습 치료에 대한 인식 제고, 그리고 광감작제 및 광 전달 시스템의 발전은 이 분야의 빠른 성장을 더욱 촉진하고 있습니다.
- 절차 기술에 따라
아시아 태평양 암 광역학 치료 시장은 시술 기법을 기준으로 체외 빔, 체강내(내시경) 전달, 간질(체내) 전달, 그리고 기타 방식으로 세분화됩니다. 2025년에는 체외 빔 분야가 비침습적 특성, 사용 편의성, 그리고 표재성 종양에 대한 효과성으로 인해 69.22%의 시장 점유율을 차지하며 시장을 주도할 것으로 예상됩니다. 선진 의료 인프라와 보험급여 정책에 힘입어 도입률이 높아지고, 암 유병률 및 인식 증가에 따른 아시아 태평양 지역의 수요 증가가 체외 빔 분야가 시장을 선도하는 데 기여하고 있습니다.
내시경적 치료 부문은 최소 침습 시술의 도입 증가, 위장관암과 흉부암의 유병률 증가, 내시경 장비의 기술적 발전, 전신적 부작용을 줄이는 표적화되고 국소화된 치료 접근 방식에 대한 선호도 증가로 인해 아시아 태평양 암 광역학 치료 시장에서 연평균 성장률 8.8%로 가장 빠르게 성장하고 있습니다.
- 질병 단계별
아시아 태평양 암 광역학 치료 시장은 질병 단계에 따라 초기 암과 후기 암으로 구분됩니다. 2025년에는 초기 암 분야가 PDT의 국소 종양 표적화 효과, 건강한 조직 손상 최소화, 그리고 더 나은 미용적 효과로 인해 81.65%의 시장 점유율을 차지하며 시장을 장악할 것으로 예상됩니다. 이 분야는 높은 환자 인지도, 최소 침습 치료에 대한 선호도, 그리고 아시아 태평양 지역에서의 광범위한 도입을 바탕으로 성장하고 있으며, 암 진단율 증가와 종양학 인프라 확충은 시장 선도력을 더욱 강화하고 있습니다.
초기 암은 최소 침습적 치료법 도입 증가, 조기 진단에 대한 인식 제고, 그리고 PDT(광역학 치료)를 통한 환자 치료 결과 개선으로 인해 아시아 태평양 암 광역학 치료 시장에서 연평균 성장률 6.8%로 가장 빠르게 성장하는 분야입니다. 초기 암은 표적 치료에 더 잘 반응하여 효능이 더 높고 부작용이 적습니다. 또한, 정부의 적극적인 지원 정책과 광감작제 및 광선 전달 시스템의 발전은 이 분야의 시장 침투를 가속화하고 있습니다.
- 환자 인구 통계별
환자 인구 통계를 기준으로 아시아 태평양 암 광역학 치료 시장은 노인, 성인, 소아로 구분됩니다. 2025년에는 노인 암 유병률 증가, 피부암 및 피부암에 대한 취약성 증가, 그리고 최소 침습적 표적 치료에 대한 선호로 인해 노인 부문이 67.74%의 시장 점유율을 차지하며 시장을 주도할 것으로 예상됩니다. 북미와 아시아 태평양 지역에서는 선진 의료 인프라와 인지도, 그리고 고령 인구 증가에 힘입어 광역학 치료 도입이 활발하게 이루어지고 있습니다.
노인층은 아시아 태평양 암 광역학 치료 시장에서 연평균 성장률 6.9%로 가장 빠르게 성장하는 분야입니다. 이는 노인층의 높은 암 유병률 때문입니다. 노화는 면역 체계를 약화시키고 다양한 암에 대한 취약성을 증가시켜 PDT와 같은 효과적이고 최소 침습적인 치료에 대한 수요를 증가시킵니다. 또한, PDT는 부작용이 적고 회복이 빠르기 때문에 공격적인 치료를 견디기 어려운 노인 환자에게 적합하여 이 분야의 시장 성장을 촉진하고 있습니다.
- 최종 사용자별
아시아 태평양 암 광역학 치료 시장은 최종 사용자 기준으로 병원, 피부과 및 피부암 클리닉, 외래 수술 센터(ASCS), 학술 및 연구 기관, 기타로 세분화됩니다. 2025년에는 병원 부문이 종합적인 인프라, 전문 종양학과의 가용성, 그리고 통합 PDT 치료 제공 능력 덕분에 41.80%의 시장 점유율을 기록하며 시장을 주도할 것으로 예상됩니다. 북미와 아시아 태평양 지역의 공립 및 사립 병원, 특히 1등급 및 2등급 병원은 선진 의료 시스템과 보험급여 지원 덕분에 도입을 주도하고 있습니다. 병원 네트워크의 성장과 종양학 서비스 확대는 전 세계적으로 암 PDT의 주요 최종 사용자로서 병원의 입지를 더욱 강화하고 있습니다.
병원은 첨단 암 치료법 도입 증가, 환자 유입 증가, 그리고 전문 종양학과의 접근성 향상으로 아시아 태평양 암 광역학 치료 시장에서 연평균 성장률 7.5%로 가장 빠르게 성장하는 분야입니다. 병원은 진단, 치료, 치료 후 관리 등 포괄적인 PDT 서비스를 제공하기 때문에 단독 진료소보다 선호됩니다. 또한, 인지도 향상, 정부 정책, 그리고 보험 적용 범위 확대는 병원 기반 PDT 도입을 더욱 촉진하고 있습니다.
- 유통 채널별
아시아 태평양 암 광역학 치료 시장은 유통 채널을 기준으로 직접 입찰, 제3자 유통업체, 온라인, 그리고 기타로 구분됩니다. 2025년에는 병원, 정부 의료 프로그램, 그리고 대형 종양학 센터의 대량 조달을 통해 직접 입찰 부문이 51.18%의 시장 점유율을 차지하며 시장을 장악할 것으로 예상됩니다. 직접 입찰은 광감작제와 PDT 기기의 비용 효율성과 안정적인 공급을 보장합니다. 북미와 아시아 태평양 지역에서는 체계적인 병원 조달 시스템과 공공 보건 입찰, 그리고 증가하는 기관 수요 덕분에 채택률이 높습니다.
직접 입찰 부문은 아시아 태평양 암 광역학 치료 시장에서 연평균 성장률 7.0%로 가장 빠르게 성장하는 부문입니다. 정부와 병원의 직접 계약을 통한 첨단 PDT 기기 조달 증가로 인해 이러한 접근 방식은 대규모 암 치료 프로그램의 비용 효율성, 신속한 조달, 그리고 안정적인 공급을 보장합니다. 또한, 공공 의료비 지출 증가, 정부의 암 치료 정책, 그리고 중앙 집중식 구매 선호는 유통업체나 온라인 채널보다 직접 입찰 도입을 촉진하고 있습니다.
아시아 태평양 암 광역학 치료 시장 지역 분석
- 중국은 2025년 아시아 태평양 암 광역학 치료 시장에서 43.73%의 최대 매출 점유율을 기록하며 시장을 장악할 것으로 예상됩니다. 이는 풍부한 환자층, 증가하는 암 유병률, 그리고 증가하는 의료비 지출에 힘입은 것입니다. 첨단 암 치료에 대한 정부의 강력한 지원, 혁신적 치료법 도입 확대, 그리고 주요 국내 PDT 기기 제조업체들의 입지가 이러한 성장세를 뒷받침합니다.
- 일본은 예측 기간 동안 아시아 태평양 암 광역학 치료 시장에서 연평균 성장률 8.9%로 가장 빠르게 성장할 것으로 예상됩니다. 이는 암 유병률 증가, 고도로 발달된 의료 인프라, 그리고 혁신적인 치료법에 대한 정부의 강력한 지원에 힘입은 것입니다. 환자와 의사의 인식 제고와 최소 침습 치료법 도입이 맞물려 수요가 급증하고 있습니다.
- 또한, 의료 인프라가 확대되고 환자와 의사의 인식도 높아졌습니다.
호주 아시아 태평양 암 광역학 치료 시장 통찰력
호주 아시아태평양 암 광역학 치료 시장은 선진 의료 인프라, 탄탄한 종양학 연구 생태계, 그리고 전문 암센터의 가용성을 바탕으로 아시아태평양 암 치료 환경에서 중요한 역할을 담당하고 있습니다. 혁신적이고 최소 침습적 치료법의 높은 도입률, 암 치료에 대한 정부 지원 정책, 그리고 피부암 발생률 증가는 시장 성장을 견인하고 있습니다. 또한, 호주 연구 기관, 대학, 그리고 글로벌 제약 회사 간의 협력은 광역학 치료(PDT)의 개발 및 상용화를 가속화하여 호주를 아시아태평양 시장의 핵심 국가로 자리매김하고 있습니다.
한국 아시아 태평양 암 광역학 치료 시장 통찰력
한국의 아시아 태평양 암 광역학 치료 시장은 잘 구축된 의료 시스템, 첨단 암 치료 기술의 빠른 도입, 그리고 종양학 치료 개선을 위한 강력한 정부 정책에 힘입어 꾸준히 성장할 것으로 예상됩니다. 위암, 간암, 폐암 등 암 유병률 증가와 PDT(광역학 치료)와 같은 최소 침습 치료법에 대한 인식 제고가 수요를 견인하고 있습니다. 유리한 보험급여 체계, R&D 투자, 그리고 병원, 대학, 그리고 글로벌 바이오 제약 회사 간의 협력은 한국의 시장 침투와 지속적인 성장을 더욱 가속화할 것입니다.
시장에서 활동하는 주요 시장 리더는 다음과 같습니다.
- Novartis Pharma AG(스위스)
- Galderma SA(스위스)
- Bausch Health Companies Inc.(캐나다)
- Photocure ASA(노르웨이)
- ADVANZ PHARMA Corp.(영국)
- Sun Pharmaceutical Industries Ltd.(인도)
- Biofrontera AG(독일)
- LUMIBIRD SA(프랑스)
- 루지틴 SA(포르투갈)
- 루메다 주식회사(스웨덴)
- ImPact Biotech(이스라엘)
- biolitec Holding GmbH & Co KG(독일)
- Modulight Corporation(핀란드)
- THERALASE TECHNOLOGIES INC. (캐나다)
아시아 태평양 암 광역학 치료 시장의 최신 동향
- 2023년 2월, 갈더마와 저먼 메디컬 엔지니어링(GME)의 협력은 피부과 및 광역학 치료(PDT) 시장의 전략적 발전을 의미합니다. 전암성 및 비흑색종 피부암 치료를 위한 선도적인 광감작제인 갈더마의 메트빅스(Metvix)와 GME의 멀티라이트(MultiLite) 기기를 결합함으로써, 이 파트너십은 갈더마의 통합 치료 솔루션을 강화하고 기존의 적색광 PDT(C-PDT)와 환자 친화적인 인공 일광 PDT(ADL-PDT)를 모두 제공할 수 있는 역량을 확대합니다.
- 2025년에 맥케슨은 코어 벤처스(커뮤니티 종양학 활성화 기업 벤처스)를 인수하여 약 24억 9천만 달러에 지배 지분의 약 70%를 인수하여 플로리다 암 전문가 및 연구소를 통해 지역 사회 기반 종양학 치료를 강화했습니다.
- 2025년에 Biofrontera AG는 Ameluz와 RhodoLED와 관련된 모든 미국 자산을 Biofrontera Inc.로 이전하여 10%의 지분과 미국 Ameluz 판매에 대한 12~15%의 로열티를 받았습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET END USER COVERAGE GRID
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 PRODUCTION CONSUMPTION ANALYSIS
4.3.1 INTRODUCTION
4.3.2 PRODUCTION SIDE ANALYSIS
4.3.2.1 PHOTOSENSITIZER MANUFACTURING
4.3.2.2 DEVICE MANUFACTURING
4.3.2.3 RESEARCH AND INNOVATION
4.3.3 CONSUMPTION SIDE ANALYSIS
4.3.3.1 CLINICAL APPLICATION
4.3.3.2 TREATMENT VOLUMES AND TRENDS
4.3.3.3 DOSAGE AND PROTOCOLS
4.3.4 PRODUCTION–CONSUMPTION DYNAMICS
4.3.4.1 SUPPLY CONSTRAINTS
4.3.4.2 REGIONAL OVERVIEW
4.3.4.3 FUTURE OUTLOOK
4.3.5 CONCLUSION
4.4 COST ANALYSIS BREAKDOWN
4.4.1 INTRODUCTION
4.4.2 DIRECT MEDICAL COSTS
4.4.2.1 COST OF PHOTOSENSITIZERS
4.4.2.2 LIGHT DELIVERY SYSTEMS
4.4.2.3 HEALTHCARE FACILITY CHARGES
4.4.3 INDIRECT COSTS
4.4.3.1 PATIENT-RELATED EXPENSES
4.4.3.2 POST-TREATMENT MONITORING
4.4.4 COMPARATIVE COST-EFFECTIVENESS
4.4.5 REIMBURSEMENT AND INSURANCE IMPACT
4.4.6 REGIONAL COST VARIATIONS
4.4.7 FUTURE COST TRENDS AND REDUCTION STRATEGIES
4.4.7.1 TECHNOLOGICAL ADVANCEMENTS
4.4.7.2 HEALTHCARE EFFICIENCY INITIATIVES
4.4.8 CONCLUSION
4.5 TECHNOLOGICAL ADVANCEMENTS
4.5.1 INTRODUCTION
4.5.2 NEXT-GENERATION PHOTOSENSITIZERS
4.5.3 ADVANCEMENTS IN LIGHT DELIVERY SYSTEMS
4.5.4 NANOTECHNOLOGY-ENABLED DELIVERY
4.5.5 COMBINATION THERAPIES AND IMMUNOMODULATION
4.5.6 DIGITAL INTEGRATION AND TREATMENT PLANNING
4.5.7 RECENT TRENDS AND OUTLOOK
4.5.8 CONCLUSION
4.6 VALUE CHAIN ANALYSIS
4.6.1 INTRODUCTION
4.6.2 RESEARCH & DEVELOPMENT
4.6.2.1 DISCOVERY OF PHOTOSENSITIZERS
4.6.2.2 DEVELOPMENT OF LIGHT DELIVERY SYSTEMS
4.6.2.3 CLINICAL TRIALS AND REGULATORY APPROVALS
4.6.3 MANUFACTURING
4.6.3.1 PRODUCTION OF PHOTOSENSITIZERS
4.6.3.2 FABRICATION OF LIGHT DELIVERY DEVICES
4.6.4 DISTRIBUTION & LOGISTICS
4.6.4.1 SUPPLY CHAIN MANAGEMENT
4.6.4.2 INTERNATIONAL TRADE AND MARKET ACCESS
4.6.5 CLINICAL APPLICATION
4.6.5.1 INTEGRATION INTO TREATMENT PROTOCOLS
4.6.5.2 TRAINING AND EDUCATION
4.6.6 POST-TREATMENT MONITORING & SUPPORT
4.6.6.1 FOLLOW-UP CARE
4.6.6.2 PATIENT SUPPORT SERVICES
4.6.7 TECHNOLOGICAL ADVANCEMENTS INFLUENCING THE PDT VALUE CHAIN
4.6.7.1 NANOTECHNOLOGY IN PDT
4.6.7.2 ARTIFICIAL INTELLIGENCE AND IMAGING
4.6.7.3 PERSONALIZED MEDICINE
4.6.8 CONCLUSION
4.7 VENDOR SELECTION CRITERIA
4.7.1 INTRODUCTION
4.7.2 CORE SELECTION CRITERIA
4.7.2.1 REGULATORY COMPLIANCE
4.7.2.2 CLINICAL EVIDENCE AND RESEARCH SUPPORT
4.7.2.3 TECHNICAL PERFORMANCE AND DEVICE COMPATIBILITY
4.7.2.4 QUALITY MANAGEMENT AND MANUFACTURING STANDARDS
4.7.2.5 SERVICE, TRAINING, AND AFTER-SALES SUPPORT
4.7.2.6 SUPPLY CHAIN RELIABILITY
4.7.3 RECENT TRENDS IN VENDOR SELECTION
4.7.4 RISK FACTORS AND VULNERABILITIES
4.7.5 KEY PERFORMANCE INDICATORS
4.7.6 STRATEGIC RECOMMENDATIONS
4.7.7 CONCLUSION
4.8 PATENT ANALYSIS
4.8.1 PATENT QUALITY AND STRENGTH
4.8.2 PATENT FAMILIES
4.8.3 LICENSING AND COLLABORATIONS
4.8.4 REGIONAL PATENT LANDSCAPE
4.8.5 IP STRATEGY AND MANAGEMENT
4.9 SUPPLY CHAIN ANALYSIS
4.9.1 OVERVIEW
4.9.2 LOGISTIC COST SCENARIO
4.9.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS
4.9.4 CONCLUSION
4.1 INDUSTRY ECOSYSTEM ANALYSIS
4.10.1 INTRODUCTION
4.10.2 ECOSYSTEM ARCHITECTURE — KEY ACTORS AND ROLES
4.10.2.1 CORE TECHNOLOGY PROVIDERS
4.10.2.2 ENABLING INSTITUTIONS
4.10.3 VALUE CHAIN AND FUNCTIONAL FLOWS
4.10.3.1 RESEARCH AND DISCOVERY
4.10.3.2 CLINICAL DEVELOPMENT AND REGULATORY VALIDATION
4.10.3.3 MANUFACTURING AND QUALITY ASSURANCE
4.10.3.4 DISTRIBUTION, PROCUREMENT AND CLINICAL ADOPTION
4.10.4 MARKET ENABLERS AND INFRASTRUCTURE
4.10.4.1 SCIENTIFIC AND REGULATORY ENABLERS
4.10.4.2 REIMBURSEMENT AND HEALTH-ECONOMICS INFRASTRUCTURE
4.10.4.3 MANUFACTURING AND SUPPLY-CHAIN CAPACITY
4.10.5 INTERDEPENDENCIES AND STRATEGIC PARTNERSHIPS
4.10.5.1 ACADEMIA-INDUSTRY TECHNOLOGY TRANSFER
4.10.5.2 VERTICAL INTEGRATION AND CONTRACT MANUFACTURING
4.10.5.3 CLINICAL NETWORKS AND KOL ECOSYSTEMS
4.10.6 RISKS, CONSTRAINTS AND SYSTEMIC VULNERABILITIES
4.10.6.1 REGULATORY COMPLEXITY FOR COMBINED PRODUCTS
4.10.6.2 SUPPLY-CHAIN CONCENTRATION AND MATERIAL RISK
4.10.6.3 EVIDENCE AND REIMBURSEMENT UNCERTAINTY
4.10.6.4 CLINICAL OPERATIONAL BARRIERS
4.10.7 STRATEGIC IMPLICATIONS AND RECOMMENDATIONS
4.10.8 OUTLOOK — EVOLUTION OF THE ECOSYSTEM
4.10.9 CONCLUSION
4.11 INNOVATION TRACKER AND STRATEGIC ANALYSIS
4.11.1 INTRODUCTION
4.11.2 RECENT TECHNOLOGICAL INNOVATIONS
4.11.2.1 ADVANCED PHOTOSENSITIZERS
4.11.2.2 OXYGEN-SELF-SUFFICIENT PLATFORMS
4.11.2.3 ALTERNATIVE ACTIVATION MODALITIES
4.11.2.4 SMART NANOPLATFORMS
4.11.2.5 NOVEL CHEMICAL STRUCTURES
4.11.3 STRATEGIC INNOVATIONS IN DELIVERY SYSTEMS
4.11.3.1 LIGHT DELIVERY DEVICES
4.11.3.2 COMBINATION THERAPIES
4.11.3.3 IMAGING INTEGRATION
4.11.4 KEY CHALLENGES
4.11.5 STRATEGIC THEMES
4.11.6 STRATEGIC IMPLICATIONS FOR MARKET PLAYERS
4.11.7 RECOMMENDATIONS
4.11.8 OUTLOOK AND STRATEGIC RISKS
4.11.9 CONCLUSION
4.12 PRICING ANALYSIS
4.12.1 INTRODUCTION
4.12.2 COMPONENTS OF THE TOTAL TREATMENT PRICE
4.12.2.1 PHOTOSENSITIZING AGENT (DRUG) COSTS
4.12.2.2 DEVICE CAPITAL AND MAINTENANCE COST
4.12.2.3 CONSUMABLES AND PROCEDURAL OVERHEAD
4.12.2.4 INDIRECT AND DOWNSTREAM COSTS
4.12.3 PRICING MODELS AND APPROACHES
4.12.3.1 COST-PLUS AND MARKUP MODELS
4.12.3.2 VALUE-BASED AND OUTCOMES-LINKED PRICING
4.12.3.3 BUNDLED PAYMENTS AND PROCEDURAL TARIFFS
4.12.3.4 SUBSCRIPTION AND MANAGED-SERVICE MODELS FOR DEVICES
4.12.4 REIMBURSEMENT LANDSCAPE
4.12.4.1 UNITED STATES: MEDICARE AND COMMERCIAL PAYERS
4.12.4.2 EUROPE AND OTHER HIGH-INCOME MARKETS
4.12.4.3 EMERGING MARKETS AND OUT-OF-POCKET DYNAMICS
4.12.5 REGIONAL PRICE DIFFERENTIALS AND DRIVERS
4.12.5.1 MANUFACTURING FOOTPRINT AND SUPPLY-CHAIN EFFECTS
4.12.5.2 REGULATORY BURDEN AND MARKET ACCESS TIMELINES
4.12.5.3 CLINICAL PRACTICE PATTERNS AND REIMBURSEMENT POLICY
4.12.6 PRICE SENSITIVITY, ACCESS, AND EQUITY
4.12.6.1 PRICE ELASTICITY IN HOSPITAL PROCUREMENT
4.12.6.2 PATIENT ACCESS AND SOCIOECONOMIC BARRIERS
4.12.7 COMPETITIVE & STRATEGIC PRICING IMPLICATIONS
4.12.7.1 DIFFERENTIATION-BASED PREMIUM PRICING
4.12.7.2 PENETRATION PRICING AND VOLUME STRATEGIES
4.12.7.3 MANAGED ENTRY AGREEMENTS AND OUTCOMES GUARANTEES
4.12.8 RECOMMENDATIONS FOR STAKEHOLDERS
4.12.8.1 FOR MANUFACTURERS
4.12.8.2 FOR PROVIDERS AND HOSPITAL SYSTEMS
4.12.8.3 FOR PAYERS AND POLICYMAKERS
4.12.9 RISKS, UNCERTAINTIES, AND FUTURE PRICE PRESSURES
4.12.10 CONCLUSION
5 TARIFFS & IMPACT ON THE MARKET
5.1 INTRODUCTION
5.2 TARIFF LANDSCAPE RELEVANT TO PDT PRODUCTS
5.2.1 CATEGORIES OF TRADE EXPOSURE
5.2.2 RECENT AND EMERGING TARIFF MEASURES OF CONSEQUENCE
5.3 DIRECT COST IMPACTS
5.3.1 INCREASED LANDED COSTS AND MARGIN COMPRESSION
5.3.2 PRICE VOLATILITY AND PROCUREMENT BUDGETING
5.4 SUPPLY-CHAIN & MANUFACTURING IMPLICATIONS
5.4.1 SUPPLIER DIVERSIFICATION AND RESHORING INCENTIVES
5.4.2 SOURCING OF HIGH-VALUE NANOMATERIALS AND COMPONENTS
5.4.3 REGULATORY AND QUALIFICATION COSTS FOR NEW SUPPLIERS
5.5 CLINICAL ACCESS, PRICING & REIMBURSEMENT EFFECTS
5.5.1 ACCESS RISK FOR PATIENTS AND PROVIDERS
5.5.2 REIMBURSEMENT PRESSURE AND HEALTH-ECONOMIC ASSESSMENTS
5.6 R&D, INNOVATION & COMPETITIVE IMPLICATIONS
5.6.1 DISRUPTION OF RESEARCH SUPPLIES AND COLLABORATION FLOWS
5.6.2 STRATEGIC REPOSITIONING AND COMPETITIVE ADVANTAGE
5.7 POLICY, COMPLIANCE & REGULATORY CONSIDERATIONS
5.7.1 USE OF WTO AND PREFERENTIAL TRADE RULES
5.7.2 TARIFF MITIGATION TOOLS AND ADVOCACY
5.8 RECOMMENDATIONS FOR STAKEHOLDERS
5.9 CONCLUSION
6 REGULATION COVERAGE
6.1 PRODUCT CODES
6.1.1 CERTIFIED STANDARDS
6.1.2 SAFETY STANDARDS
6.1.3 MATERIAL HANDLING & STORAGE
6.1.4 TRANSPORT & PRECAUTIONS
6.1.5 HAZARD IDENTIFICATION
6.1.6 CONCLUSION
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF CANCER
7.1.2 GROWING PREFERENCE FOR MINIMALLY INVASIVE THERAPIES
7.1.3 TECHNOLOGICAL ADVANCEMENTS IN PHOTOSENSITIZERS AND DEVICES
7.1.4 EXPANDING RESEARCH AND CLINICAL DEVELOPMENT PIPELINE
7.2 RESTRAINTS
7.2.1 LIMITED DEPTH OF LIGHT PENETRATION
7.2.2 HIGH COST OF TREATMENT
7.3 OPPORTUNITIES
7.3.1 INTEGRATION WITH OTHER CANCER THERAPIES
7.3.2 DEVELOPMENT OF NOVEL PHOTOSENSITIZERS
7.3.3 M&A AND PARTNERSHIPS WITH ONCOLOGY DEVICE/LASER FIRMS AND PHARMA
7.4 CHALLENGES
7.4.1 TUMOR HYPOXIA AS A BIOLOGICAL BARRIER TO PHOTODYNAMIC THERAPY EFFICACY
7.4.2 COMPETITION FROM ALTERNATIVE TREATMENTS
8 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 PHOTOSENSITIZER DRUGS
8.3 PHOTODYNAMIC THERAPY DEVICES
9 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION
9.1 OVERVIEW
9.2 SKIN & CUTANEOUS ONCOLOGY
9.3 HEAD & NECK
9.4 ESOPHAGAL
9.5 LUNG
9.6 BLADDER
9.7 CERVICAL
9.8 PROSTATE
10 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY
10.1 OVERVIEW
10.2 STANDALONE THERAPY
10.3 ADJUNCTIVE THERAPY
10.4 PALLIATION THERAPY
10.5 OTHERS
11 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE
11.1 OVERVIEW
11.2 EXTERNAL BEAM
11.3 INTRACAVITARY (ENDOSCOPIC) DELIVERY
11.4 INTERSTITIAL (INTERNAL) DELIVERY
11.5 OTHERS
12 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE
12.1 OVERVIEW
12.2 EARLY-STAGE CANCER
12.3 LATE-STAGE CANCER
13 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS
13.1 OVERVIEW
13.2 GERIATRIC
13.3 ADULTS
13.4 PEDIATRIC
14 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER
14.1 OVERVIEW
14.2 HOSPITALS
14.3 DERMATOLOGY & SKIN-CANCER CLINICS
14.4 AMBULATORY SURGICAL CENTERS (ASCS)
14.5 ACADEMIC & RESEARCH INSTITUTES
14.6 OTHERS
15 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 DIRECT TENDER
15.3 THIRD PARTY DISTRIBUTORS
15.4 ONLINE
15.5 OTHERS
16 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION
16.1 ASIA-PACIFIC
16.1.1 CHINA
16.1.2 JAPAN
16.1.3 SOUTH KOREA
16.1.4 AUSTRAILA
16.1.5 TAIWAN
16.1.6 INDIA
16.1.7 INDONESIA
16.1.8 HONG KONG
16.1.9 NEW ZEALAND
16.1.10 SINGAPORE
16.1.11 PHILIPPINES
16.1.12 THAILAND
16.1.13 MALAYSIA
16.1.14 REST OF ASIA-PACIFIC
17 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET : COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: GLOBAL
18 SWOT ANALYSIS
19 COMPANY PROFILE
19.1 NOVERTIS AG
19.1.1 COMPANY SNAPSHOT
19.1.2 REVENUE ANALYSIS
19.1.3 COMPANY SHARE ANALYSIS
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT DEVELOPMENT
19.2 GALDERMA S. A.
19.2.1 COMPANY SNAPSHOT
19.2.2 REVENUE ANALYSIS
19.2.3 COMPANY SHARE ANALYSIS
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT DEVELOPMENTS
19.3 PHOTOCURE
19.3.1 COMPANY SNAPSHOT
19.3.2 REVENUE ANALYSIS
19.3.3 COMPANY SHARE ANALYSIS
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPMENT
19.4 ADVANZ PHARMA CORP.
19.4.1 COMPANY SNAPSHOT
19.4.2 COMPANY SHARE ANALYSIS
19.4.3 PRODUCT PORTFOLIO
19.4.4 RECENT DEVELOPMENT
19.5 AMERISOURCE BERGEN CORPORATION
19.5.1 COMPANY SNAPSHOT
19.5.2 REVENUE ANALYSIS
19.5.3 COMPANY SHARE ANALYSIS
19.5.4 PRODUCT PORTFOLIO
19.5.5 RECENT DEVELOPMENT
19.6 BIOFRONTERA AG
19.6.1 COMPANY SNAPSHOT
19.6.2 REVENUE ANALYSIS
19.6.3 PRODUCT PORTFOLIO
19.6.4 RECENT DEVELOPMENTS
19.7 BIOLITEC HOLDING GMBH & CO KG
19.7.1 COMPANY SNAPSHOT
19.7.2 PRODUCT PORTFOLIO
19.7.3 RECENT DEVELOPMENT
19.8 CARDINAL HEALTH
19.8.1 COMPANY SNAPSHOT
19.8.2 REVENUE ANALYSIS
19.8.3 PRODUCT PORTFOLIO
19.8.4 RECENT DEVELOPMENT
19.9 HEMERION THERAPEUTICS
19.9.1 COMPANY SNAPSHOT
19.9.2 PRODUCT PORTFOLIO
19.9.3 RECENT DEVELOPMENTS
19.1 IMPACT BIOTECH
19.10.1 COMPANY SNAPSHOT
19.10.2 PRODUCT PORTFOLIO
19.10.3 RECENT DEVELOPMENTS
19.11 INOVA
19.11.1 COMPANY SNAPSHOT
19.11.2 PRODUCT PORTFOLIO
19.11.3 RECENT DEVELOPMENT
19.12 LUMIBIRD
19.12.1 COMPANY SNAPSHOT
19.12.2 REVENUE ANALYSIS
19.12.3 PRODUCT PORTFOLIO
19.12.4 RECENT DEVELOPMENT
19.13 LUZITIN
19.13.1 COMPANY SNAPSHOT
19.13.2 PRODUCT PORTFOLIO
19.13.3 RECENT DEVELOPMENT
19.14 MCKESSON
19.14.1 COMPANY SNAPSHOT
19.14.2 REVENUE ANALYSIS
19.14.3 PRODUCT PORTFOLIO
19.14.4 RECENT DEVELOPMENTS
19.15 MODULIGHT CORPORATION
19.15.1 COMPANY SNAPSHOT
19.15.2 REVENUE ANALYSIS
19.15.3 PRODUCT PORTFOLIO
19.15.4 RECENT DEVELOPMENT
19.16 ONCOLUX INC (FORMERLY LUMEDA INC.)
19.16.1 COMPANY SNAPSHOT
19.16.2 PRODUCT PORTFOLIO
19.16.3 RECENT DEVELOPMENT
19.17 SUN PHARMACEUTICAL INDUSTRIES LTD
19.17.1 COMPANY SNAPSHOT
19.17.2 REVENUE ANALYSIS
19.17.3 PRODUCT PORTFOLIO
19.17.4 RECENT DEVELOPMENT
19.18 THERALASE TECHNOLOGIES INC.
19.18.1 COMPANY SNAPSHOT
19.18.2 REVENUSE ANALYSIS
19.18.3 PRODUCT PORTFOLIO
19.18.4 RECENT DEVELOPMENT
20 QUESTIONNAIRE
21 RELATED REPORTS
표 목록
TABLE 1 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 2 ASIA-PACIFIC PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 3 ASIA-PACIFIC PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 4 ASIA-PACIFIC PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 5 ASIA-PACIFIC PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 6 ASIA-PACIFIC PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 7 ASIA-PACIFIC LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 8 ASIA-PACIFIC ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 9 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 10 ASIA-PACIFIC SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 11 ASIA-PACIFIC SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 12 ASIA-PACIFIC SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 13 ASIA-PACIFIC HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 14 ASIA-PACIFIC HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 15 ASIA-PACIFIC HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 16 ASIA-PACIFIC ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 17 ASIA-PACIFIC ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 18 ASIA-PACIFIC ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 19 ASIA-PACIFIC LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 20 ASIA-PACIFIC LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 21 ASIA-PACIFIC LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 22 ASIA-PACIFIC BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 23 ASIA-PACIFIC BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 24 ASIA-PACIFIC BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 25 ASIA-PACIFIC CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 26 ASIA-PACIFIC CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 27 ASIA-PACIFIC CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 28 ASIA-PACIFIC PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 29 ASIA-PACIFIC PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 30 ASIA-PACIFIC PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 31 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 32 ASIA-PACIFIC STANDALONE THERAPY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 33 ASIA-PACIFIC ADJUNCTIVE THERAPY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 34 ASIA-PACIFIC PALLIATION THERAPY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 35 ASIA-PACIFIC OTHERS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 36 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 37 ASIA-PACIFIC EXTERNAL BEAM IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 38 ASIA-PACIFIC INTRACAVITARY (ENDOSCOPIC) DELIVERY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 39 ASIA-PACIFIC INTERSTITIAL (INTERNAL) DELIVERY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 40 ASIA-PACIFIC OTHERS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 41 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 42 ASIA-PACIFIC EARLY-STAGE CANCER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 43 ASIA-PACIFIC LATE-STAGE CANCER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 44 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 45 ASIA-PACIFIC GERIATRIC IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 46 ASIA-PACIFIC ADULTS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 47 ASIA-PACIFIC PEDIATRIC IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 48 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 49 ASIA-PACIFIC HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 50 ASIA-PACIFIC HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 51 ASIA-PACIFIC HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 52 ASIA-PACIFIC DERMATOLOGY & SKIN-CANCER CLINICS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 53 ASIA-PACIFIC AMBULATORY SURGICAL CENTERS (ASCS) IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 54 ASIA-PACIFIC ACADEMIC & RESEARCH INSTITUTES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 55 ASIA-PACIFIC OTHERS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 56 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 57 ASIA-PACIFIC DIRECT TENDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 58 ASIA-PACIFIC THIRD PARTY DISTRIBUTORS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 59 ASIA-PACIFIC ONLINE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 60 ASIA-PACIFIC OTHERS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 61 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 62 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 63 ASIA-PACIFIC PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 64 ASIA-PACIFIC PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 65 ASIA-PACIFIC PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 66 ASIA-PACIFIC LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 67 ASIA-PACIFIC ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 68 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 69 ASIA-PACIFIC SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 70 ASIA-PACIFIC SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 71 ASIA-PACIFIC HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 72 ASIA-PACIFIC HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 73 ASIA-PACIFIC ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 74 ASIA-PACIFIC ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 75 ASIA-PACIFIC LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 76 ASIA-PACIFIC LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 77 ASIA-PACIFIC BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 78 ASIA-PACIFIC BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 79 ASIA-PACIFIC CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 80 ASIA-PACIFIC CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 81 ASIA-PACIFIC PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 82 ASIA-PACIFIC PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 83 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 84 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 85 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 86 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 87 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 88 ASIA-PACIFIC HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 ASIA-PACIFIC HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 90 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 91 CHINA CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 92 CHINA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 93 CHINA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 94 CHINA PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 95 CHINA LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 96 CHINA ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 97 CHINA CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 98 CHINA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 99 CHINA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 100 CHINA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 101 CHINA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 102 CHINA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 103 CHINA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 104 CHINA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 105 CHINA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 106 CHINA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 107 CHINA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 108 CHINA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 109 CHINA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 110 CHINA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 111 CHINA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 112 CHINA CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 113 CHINA CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 114 CHINA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 115 CHINA CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 116 CHINA CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 117 CHINA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 118 CHINA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 119 CHINA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 120 JAPAN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 121 JAPAN PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 122 JAPAN PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 123 JAPAN PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 124 JAPAN LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 125 JAPAN ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 126 JAPAN CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 127 JAPAN SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 128 JAPAN SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 129 JAPAN HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 130 JAPAN HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 131 JAPAN ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 132 JAPAN ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 133 JAPAN LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 134 JAPAN LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 135 JAPAN BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 136 JAPAN BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 137 JAPAN CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 138 JAPAN CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 139 JAPAN PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 140 JAPAN PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 141 JAPAN CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 142 JAPAN CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 143 JAPAN CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 144 JAPAN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 145 JAPAN CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 146 JAPAN HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 147 JAPAN HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 148 JAPAN CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 149 SOUTH KOREA CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 150 SOUTH KOREA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 151 SOUTH KOREA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 152 SOUTH KOREA PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 153 SOUTH KOREA LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 154 SOUTH KOREA ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 155 SOUTH KOREA CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 156 SOUTH KOREA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 157 SOUTH KOREA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 158 SOUTH KOREA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 159 SOUTH KOREA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 160 SOUTH KOREA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 161 SOUTH KOREA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 162 SOUTH KOREA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 163 SOUTH KOREA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 164 SOUTH KOREA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 165 SOUTH KOREA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 166 SOUTH KOREA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 167 SOUTH KOREA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 168 SOUTH KOREA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 169 SOUTH KOREA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 170 SOUTH KOREA CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 171 SOUTH KOREA CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 172 SOUTH KOREA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 173 SOUTH KOREA CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 174 SOUTH KOREA CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 175 SOUTH KOREA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 176 SOUTH KOREA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 177 SOUTH KOREA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 178 AUSTRALIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 179 AUSTRALIA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 180 AUSTRALIA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 181 AUSTRALIA PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 182 AUSTRALIA LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 183 AUSTRALIA ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 184 AUSTRALIA CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 185 AUSTRALIA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 186 AUSTRALIA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 187 AUSTRALIA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 188 AUSTRALIA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 189 AUSTRALIA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 190 AUSTRALIA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 191 AUSTRALIA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 192 AUSTRALIA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 193 AUSTRALIA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 194 AUSTRALIA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 195 AUSTRALIA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 196 AUSTRALIA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 197 AUSTRALIA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 198 AUSTRALIA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 199 AUSTRALIA CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 200 AUSTRALIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 201 AUSTRALIA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 202 AUSTRALIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 203 AUSTRALIA CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 204 AUSTRALIA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 205 AUSTRALIA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 206 AUSTRALIA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 207 TAIWAN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 208 TAIWAN PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 209 TAIWAN PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 210 TAIWAN PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 211 TAIWAN LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 212 TAIWAN ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 213 TAIWAN CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 214 TAIWAN SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 215 TAIWAN SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 216 TAIWAN HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 217 TAIWAN HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 218 TAIWAN ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 219 TAIWAN ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 220 TAIWAN LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 221 TAIWAN LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 222 TAIWAN BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 223 TAIWAN BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 224 TAIWAN CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 225 TAIWAN CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 226 TAIWAN PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 227 TAIWAN PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 228 TAIWAN CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 229 TAIWAN CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 230 TAIWAN CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 231 TAIWAN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 232 TAIWAN CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 233 TAIWAN HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 234 TAIWAN HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 235 TAIWAN CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 236 INDIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 237 INDIA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 238 INDIA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 239 INDIA PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 240 INDIA LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 241 INDIA ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 242 INDIA CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 243 INDIA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 244 INDIA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 245 INDIA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 246 INDIA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 247 INDIA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 248 INDIA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 249 INDIA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 250 INDIA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 251 INDIA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 252 INDIA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 253 INDIA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 254 INDIA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 255 INDIA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 256 INDIA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 257 INDIA CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 258 INDIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 259 INDIA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 260 INDIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 261 INDIA CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 262 INDIA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 263 INDIA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 264 INDIA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 265 INDONESIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 266 INDONESIA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 267 INDONESIA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 268 INDONESIA PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 269 INDONESIA LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 270 INDONESIA ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 271 INDONESIA CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 272 INDONESIA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 273 INDONESIA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 274 INDONESIA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 275 INDONESIA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 276 INDONESIA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 277 INDONESIA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 278 INDONESIA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 279 INDONESIA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 280 INDONESIA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 281 INDONESIA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 282 INDONESIA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 283 INDONESIA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 284 INDONESIA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 285 INDONESIA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 286 INDONESIA CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 287 INDONESIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 288 INDONESIA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 289 INDONESIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 290 INDONESIA CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 291 INDONESIA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 292 INDONESIA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 293 INDONESIA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 294 HONG KONG CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 295 HONG KONG PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 296 HONG KONG PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 297 HONG KONG PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 298 HONG KONG LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 299 HONG KONG ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 300 HONG KONG CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 301 HONG KONG SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 302 HONG KONG SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 303 HONG KONG HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 304 HONG KONG HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 305 HONG KONG ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 306 HONG KONG ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 307 HONG KONG LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 308 HONG KONG LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 309 HONG KONG BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 310 HONG KONG BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 311 HONG KONG CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 312 HONG KONG CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 313 HONG KONG PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 314 HONG KONG PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 315 HONG KONG CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 316 HONG KONG CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 317 HONG KONG CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 318 HONG KONG CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 319 HONG KONG CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 320 HONG KONG HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 321 HONG KONG HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 322 HONG KONG CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 323 NEW ZEALAND CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 324 NEW ZEALAND PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 325 NEW ZEALAND PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 326 NEW ZEALAND PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 327 NEW ZEALAND LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 328 NEW ZEALAND ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 329 NEW ZEALAND CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 330 NEW ZEALAND SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 331 NEW ZEALAND SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 332 NEW ZEALAND HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 333 NEW ZEALAND HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 334 NEW ZEALAND ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 335 NEW ZEALAND ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 336 NEW ZEALAND LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 337 NEW ZEALAND LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 338 NEW ZEALAND BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 339 NEW ZEALAND BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 340 NEW ZEALAND CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 341 NEW ZEALAND CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 342 NEW ZEALAND PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 343 NEW ZEALAND PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 344 NEW ZEALAND CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 345 NEW ZEALAND CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 346 NEW ZEALAND CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 347 NEW ZEALAND CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 348 NEW ZEALAND CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 349 NEW ZEALAND HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 350 NEW ZEALAND HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 351 NEW ZEALAND CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 352 SINGAPORE CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 353 SINGAPORE PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 354 SINGAPORE PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 355 SINGAPORE PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 356 SINGAPORE LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 357 SINGAPORE ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 358 SINGAPORE CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 359 SINGAPORE SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 360 SINGAPORE SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 361 SINGAPORE HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 362 SINGAPORE HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 363 SINGAPORE ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 364 SINGAPORE ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 365 SINGAPORE LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 366 SINGAPORE LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 367 SINGAPORE BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 368 SINGAPORE BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 369 SINGAPORE CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 370 SINGAPORE CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 371 SINGAPORE PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 372 SINGAPORE PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 373 SINGAPORE CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 374 SINGAPORE CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 375 SINGAPORE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 376 SINGAPORE CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 377 SINGAPORE CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 378 SINGAPORE HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 379 SINGAPORE HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 380 SINGAPORE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 381 PHILIPPINES CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 382 PHILIPPINES PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 383 PHILIPPINES PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 384 PHILIPPINES PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 385 PHILIPPINES LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 386 PHILIPPINES ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 387 PHILIPPINES CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 388 PHILIPPINES SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 389 PHILIPPINES SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 390 PHILIPPINES HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 391 PHILIPPINES HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 392 PHILIPPINES ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 393 PHILIPPINES ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 394 PHILIPPINES LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 395 PHILIPPINES LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 396 PHILIPPINES BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 397 PHILIPPINES BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 398 PHILIPPINES CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 399 PHILIPPINES CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 400 PHILIPPINES PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 401 PHILIPPINES PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 402 PHILIPPINES CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 403 PHILIPPINES CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 404 PHILIPPINES CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 405 PHILIPPINES CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 406 PHILIPPINES CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 407 PHILIPPINES HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 408 PHILIPPINES HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 409 PHILIPPINES CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 410 THAILAND CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 411 THAILAND PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 412 THAILAND PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 413 THAILAND PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 414 THAILAND LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 415 THAILAND ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 416 THAILAND CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 417 THAILAND SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 418 THAILAND SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 419 THAILAND HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 420 THAILAND HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 421 THAILAND ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 422 THAILAND ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 423 THAILAND LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 424 THAILAND LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 425 THAILAND BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 426 THAILAND BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 427 THAILAND CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 428 THAILAND CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 429 THAILAND PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 430 THAILAND PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 431 THAILAND CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 432 THAILAND CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 433 THAILAND CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 434 THAILAND CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 435 THAILAND CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 436 THAILAND HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 437 THAILAND HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 438 THAILAND CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 439 MALAYSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 440 MALAYSIA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 441 MALAYSIA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 442 MALAYSIA PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 443 MALAYSIA LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 444 MALAYSIA ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 445 MALAYSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 446 MALAYSIA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 447 MALAYSIA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 448 MALAYSIA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 449 MALAYSIA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 450 MALAYSIA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 451 MALAYSIA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 452 MALAYSIA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 453 MALAYSIA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 454 MALAYSIA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 455 MALAYSIA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 456 MALAYSIA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 457 MALAYSIA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 458 MALAYSIA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 459 MALAYSIA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 460 MALAYSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 461 MALAYSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 462 MALAYSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 463 MALAYSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 464 MALAYSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 465 MALAYSIA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 466 MALAYSIA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 467 MALAYSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 468 REST OF ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
그림 목록
FIGURE 1 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: ASIA-PACIFIC VS REGIONAL ANALYSIS
FIGURE 5 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: SEGMENTATION
FIGURE 10 EXECUTIVE SUMMARY
FIGURE 11 STRATEGIC DECISIONS
FIGURE 12 TWO SEGMENTS COMPRISE THE ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE (2024)
FIGURE 13 INCREASING PREVALENCE OF CANCER ACROSS GLOBE EXPECTED TO DRIVE THE ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 14 PHOTOSENSITIZER DRUGS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET IN 2025 & 2032
FIGURE 15 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET-MARKET OVERVIEW
FIGURE 16 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2024
FIGURE 17 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2024
FIGURE 18 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032
FIGURE 19 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032
FIGURE 20 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2024
FIGURE 21 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2024
FIGURE 22 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032
FIGURE 23 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032
FIGURE 24 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2024
FIGURE 25 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2024
FIGURE 26 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032
FIGURE 27 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032
FIGURE 28 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2024
FIGURE 29 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2024
FIGURE 30 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032
FIGURE 31 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032
FIGURE 32 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2024
FIGURE 33 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2024
FIGURE 34 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032
FIGURE 35 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032
FIGURE 36 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2024
FIGURE 37 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032
FIGURE 38 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032
FIGURE 39 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032
FIGURE 40 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2024
FIGURE 41 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2024
FIGURE 42 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032
FIGURE 43 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032
FIGURE 44 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024
FIGURE 45 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024
FIGURE 46 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032
FIGURE 47 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032
FIGURE 48 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: SNAPSHOT (2024)
FIGURE 49 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: COMPANY SHARE 2024 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
